Tag Archives: American Heart Association

POZEN Announces Results from a Burden of Cardiovascular Disease Study: a Managed Care Perspective

By Business Wirevia The Motley Fool

Filed under:

POZEN Announces Results from a Burden of Cardiovascular Disease Study: a Managed Care Perspective

Presentation at AMCP Demonstrates Cost Reduction When PPI Used in Combination With Aspirin for Both Commercial and Medicare Populations

CHAPEL HILL, N.C.–(BUSINESS WIRE)– POZEN Inc. (Nasdaq: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, announced the results of a POZEN sponsored study at the Academy of Managed Care Pharmacy’s 25th Annual Meeting and Expo on April 4, 2013. Ryan S. Clark, Pharm.D., MBA, Health Outcomes and Managed Markets Fellow, Global Health Economics & Outcomes Research at Xcenda, presented the abstract, The Burden of Secondary Cardiovascular Disease in Commercial and Medicare Patients: A Managed Care Perspective. The secondary prevention of cardiovascular events includes the daily use of aspirin. Chronic aspirin therapy is associated with significant gastrointestinal (GI) toxicity including dyspepsia, gastric ulcers and GI bleeding, all of which contribute to the disease and cost burden of secondary prevention. The GI toxicity of aspirin can be mitigated by the use of proton pump inhibitors (PPIs). The Xcenda analysis demonstrated that the prevention of cardiovascular events with aspirin, plus a PPI, compared to aspirin alone is associated with a net per-patient per-year cost decrease of $103 and $145 and a potential overall cost decrease of $1.8 million and $11.0 million for a typical one million-member Commercial and Medicare Plan, respectively.

“The overall cost of secondary cardiovascular events in patients with a history of coronary heart disease, transient ischemic attack, or ischemic stroke represents a significant financial burden on managed care,” said Rashad Carlton, Pharm.D., MSPH, Assistant Director, Global Health Economics & Outcomes Research at Xcenda. “Despite American College of Cardiology and American Heart Association guideline recommendations to start aspirin therapy and continue indefinitely in all patients unless contraindicated, aspirin remains underutilized.”

About the Study

The primary objective of the study was to characterize the financial burden of secondary cardiovascular disease and its long-term complications in patients at risk for a secondary cardiovascular event.

An economic model designed to yield the annual secondary cardiovascular disease cost burden was constructed using literature-based population, medication discontinuation/non-adherence, and cardiovascular event incidence data. Care records of secondary cardiovascular disease patients were reviewed based on treatment either with aspirin, aspirin + PPI, or no aspirin. Secondary events were calculated based on annual recurrence rates adjusted for treatment discontinuation/non-adherence. The treatment cohort cost per member and …read more

Source: FULL ARTICLE at DailyFinance

Eating More Fiber Could Lower Your Risk Of Having A Stroke

By The Huffington Post News Editors

Taking steps to include more fiber in your diet could help to protect you from suffering a stroke, a new review of studies suggests.

New research published in the journal Stroke shows that increasing dietary fiber intake by 7 grams every day is associated with a 7 percent lower risk of having a stroke for the first time. (Food-wise, 7 grams of fiber translates to two servings of produce and one serving of whole wheat pasta.)

“Most people do not get the recommended level of fiber, and increasing fiber may contribute to lower risk for strokes,” study researcher Diane Threapleton, M.Sc., who is a Ph.D. candidate in food science and nutrition at the University of Leeds, said in a statement. “We must educate consumers on the continued importance of increasing fiber intake and help them learn how to increase fiber in their diet.” According to the American Heart Association, people should aim to consume 25 grams of fiber a day.

Read More…
More on Food

…read more
Source: FULL ARTICLE at Huffington Post

Controversial NIH Chelation Trial Published In JAMA

By Larry Husten Final results of the troubled NIH-sponsored TACT trial testing chelation therapy for coronary disease have now been published in JAMA. Last November, when the preliminary results were presented at the American Heart Association meeting, the positive finding in favor of chelation therapy surprised many observers, though the investigators and senior AHA representatives expressed considerable caution about the proper interpretation of the results. Full publication of the main results should now allow for a more thorough consideration of the trial. …read more
Source: FULL ARTICLE at Forbes Technology

BankUnited Announces Leadership Team in New York

By Business Wirevia The Motley Fool

Filed under:

BankUnited Announces Leadership Team in New York

Former Capital One, North Fork Execs Join BankUnited

MIAMI LAKES, Fla.–(BUSINESS WIRE)– BankUnited today announced the hiring of a top executive to head New York banking operations, as well as its team leader of commercial private banking in New York, according to Chairman, President and CEO John Kanas.

Joe Roberto, president of New York banking operations and senior executive vice president of BankUnited. (Photo: Business Wire)

Joe Roberto will serve as president of New York banking operations and senior executive vice president of BankUnited. Roberto held leadership positions at North Fork Bank for eight years before the bank was acquired by Capital One. Most recently he was responsible for the management of Capital One‘s New York City deposit portfolio as senior vice president. In addition, Roberto had seven commercial real estate teams reporting to him in the New York, Boston, Mid-Atlantic and South-Central markets.

Roberto is a founding board member of the Huntington/East Farmingdale Chamber of Commerce and has chaired or served on committees for AHRC-Suffolk County, Southampton Youth Services, Brookhaven Memorial Hospital, Great South Bay YMCA, Special Olympics, United Cerebral Palsy, American Cancer Society, American Heart Association, and Long Island Hispanic Chamber of Commerce. He was awarded the Distinguished Citizen Award by the 23rd Street Association in 2007 for outstanding community service. Roberto currently serves as a community board member at North Shore LIJ-South Side Hospital in Bay Shore. He is a graduate of Long Island University – C.W. Post Campus and resides with his family in Bay Shore, NY.

Kelly Sheehan joins BankUnited from Capital One, and will serve as team leader of commercial private banking in New York and senior vice president. Sheehan has worked in retail and commercial banking for the past 10 years, most recently as senior vice president of Capital One‘s commercial real estate group. She was responsible for managing a team of eight professionals providing cash management solutions to some of New York City’s largest real estate owners. Sheehan began her career with North Fork Bank in 2002. She earned a bachelor’s degree in business management from Quinnipiac University in Hamden, Connecticut.


About …read more
Source: FULL ARTICLE at DailyFinance

Sibling Death Increases Risk Of Heart Attack

A person whose sibling has died is at increased risk of suffering a fatal heart attack. The finding came from a new study published in the Journal of the American Heart Association which suggests that a healthy approach can help people cope with their loss and sadness. For the purpose of the research, health records of 1… …read more
Source: FULL ARTICLE at Medical News Today

Auctions: Chevrolet Camaro COPO Convertible jumps from SEMA to Barrett-Jackson, pockets $400k for charity [w/video]

By Jeremy Korzeniewski

Filed under: , , ,

2012 Chevrolet Camaro COPO Convertible

Back at the 2012 SEMA event in Las Vegas, Chevrolet unveiled the car you see above, a 2012 Chevrolet Camaro COPO Convertible. Actually, that’s not quite accurate – this car is THE 2012 Chevrolet Camaro COPO Convertible. As in, the only one ever sold. There was one more produced, but it’s not leaving the GM Heritage Center any time soon. This one was just sold at Barrett-Jackson in Scottsdale for $400,000 exactly.

That sum will be donated to the American Heart Association, and the winner will take home this Inferno Orange Metallic COPO, complete with a 327-cubic-inch V8 topped by a 4.0-liter supercharger. The engine sends 550 horsepower to the rear drag slicks through a three-speed Powerglide automatic transmission. Perfect for a run down the quarter mile, top-down style.

Check out our high-res image gallery from the block at Barrett-Jackson above, and don’t forget to watch a video of the COPO being auctioned below, along with the car’s official auction description. And don’t forget to play along with the crowd at the Hagerty Fantasy Bid game online for a chance to win a custom 2013 Shelby GT500.

Continue reading Chevrolet Camaro COPO Convertible jumps from SEMA to Barrett-Jackson, pockets $400k for charity [w/video]

Chevrolet Camaro COPO Convertible jumps from SEMA to Barrett-Jackson, pockets $400k for charity [w/video] originally appeared on Autoblog on Sat, 19 Jan 2013 17:10:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

Source: FULL ARTICLE at Autoblog

Large Meta-Analysis Finds No Harm Associated With Eggs

By Larry Husten No food has had more ups and downs over the last century or so than the common egg. Following a long period in which eggs were ubiquitous and highly regarded, eggs fell from favor with the rise of concerns over cholesterol. Currently the American Heart Association recommends that people restrict dietary cholesterol to 300 mg per day, which effectively limits people to 1 egg per day at most. However, the relationship of dietary cholesterol and serum cholesterol is, at best, tenuous, and a significant number of experts now believe that egg consumption poses no risk to cardiovascular health.
Source: FULL ARTICLE at Forbes Health

Two Retractions For Embattled Chief Investigator Of Kyoto Heart Study

By Larry Husten, Contributor The editor of Circulation Journal, the official journal of the Japanese Circulation Society (and not to be confused with the American Heart Association‘s better known Circulation) has announced the retraction of two substudies from the Kyoto Heart Study. The papers, according to the editor, “contain a number of serious errors in data analysis.” The announcement […]
Source: FULL ARTICLE at Forbes Latest